Patent · US Active

Anti-CD40 antibodies and uses thereof

US12134653B2 · kind B2 · utility

0Cited by

8References

16Claims

0Family size

Assignee

Eucure (Beijing) Biopharma Co., Ltd · CN

Inventors

Yi Yan Yang · Singapore, SG
Chunyan Dong · Beijing, CN
Fang Yang · Beijing, CN
Chengyuan Lu · Beijing, CN
Yuelei Shen · Beijing, CN
Jian Ni · Rockville, US
Yanan Guo · Beijing, CN
Yunyun Chen · Beijing, CN
Jingshu Xie · Beijing, CN

Key dates

Filing date	Sep 8, 2021
Grant date	Nov 5, 2024
Priority date	—
Expiry date	Apr 8, 2042

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/94
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

This disclosure relates to anti-CD40 (TNF Receptor Superfamily Member 5) antibodies, antigen-binding fragments, and the uses thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.